A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will progress in patients, a new study suggests.

Diagnosing ALS is a challenge, but new research has found a highly effective way to detect and track the disease using blood biomarkers. The study compared three types of biomarkers and found that neurofilament light chain proteins stood out as the most reliable indicator,

Amyotrophic lateral sclerosis (ALS) can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at identifying and monitoring ALS.